第一作者机构:[1]Peking Univ, Dept Hematol, Canc Hosp Yunnan, Kunming, Yunnan, Peoples R China
推荐引用方式(GB/T 7714):
Lai X.,Li Z-F.,Chen K.,et al.Orelabrutinib-based regimens in chronic lymphocytic leukemia with comorbidities: A real-world study[J].ANNALS OF ONCOLOGY.2024,35:S610-S611.doi:10.1016/j.annonc.2024.08.891.
APA:
Lai, X.,Li, Z-F.,Chen, K.,Hu, X.&Liu, L..(2024).Orelabrutinib-based regimens in chronic lymphocytic leukemia with comorbidities: A real-world study.ANNALS OF ONCOLOGY,35,
MLA:
Lai, X.,et al."Orelabrutinib-based regimens in chronic lymphocytic leukemia with comorbidities: A real-world study".ANNALS OF ONCOLOGY 35.(2024):S610-S611